Table 2. Factors affecting recurrence and progression-free survival in total patients using univariate survival analysis.

Factors	Recurrence-free survival		Progression-free survival
	OR (95% CI)	P value	OR (95% CI)	P value
Age (≥ median age)	1.02 (1.01-1.04)	0.001	1.04 (1.02-1.06)	0.001
Gender (female)	0.88 (0.60-1.27)	0.485	1.05 (0.58-1.89)	0.880
BMI (≥ 25)	0.99 (0.95-1.03)	0.597	0.96 (0.90-1.03)	0.288
DM	1.42 (1.06-1.91)	0.021	1.79 (1.13-2.84)	0.013
Hypertension	1.95 (0.92-1.55)	0.183	1.33 (0.87-2.04)	0.193
Intravesical treatment	1.22 (0.92-1.63)	0.172	0.99 (0.63-1.56)	0.975
Grade (high grade)	1.55 (1.19-2.01)	0.001	4.57 (2.92-7.15)	0.001
Stage (T1)	1.34 (1.02-1.74)	0.033	3.67 (2.38-5.65)	0.001
Multiplicity (≥ 3)	1.80 (1.39-2.33)	0.001	2.55 (1.63-3.98)	0.001
Size (≥ 3 cm)	0.97 (0.73-1.29)	0.853	1.04 (0.65-1.65)	0.879
Creatinine (> 1.5 mg/dL)	1.24 (1.04-1.47)	0.014	1.23 (0.98-1.56)	0.078
Smoking	0.90 (0.70-1.17)	0.471	0.79 (0.51-1.21)	0.282